98 related articles for article (PubMed ID: 7504473)
1. Altered ligand specificity of proteolysed insulin-like growth factor binding protein-3.
Baxter RC; Skriver L
Biochem Biophys Res Commun; 1993 Nov; 196(3):1267-73. PubMed ID: 7504473
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the binding defect in insulin-like growth factor binding protein-3 from pregnancy serum.
Baxter RC; Suikkari AM; Martin JL
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):847-52. PubMed ID: 7691057
[TBL] [Abstract][Full Text] [Related]
3. Measurement of intact insulin-like growth factor-binding protein-3 in human plasma using a ligand immunofunctional assay.
Lassarre C; Binoux M
J Clin Endocrinol Metab; 2001 Mar; 86(3):1260-6. PubMed ID: 11238518
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
5. The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor.
Bayne ML; Applebaum J; Chicchi GG; Miller RE; Cascieri MA
J Biol Chem; 1990 Sep; 265(26):15648-52. PubMed ID: 2168421
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor (IGF) binding protein-3 in pregnancy serum binds native IGF-I but not iodo-IGF-I.
Suikkari AM; Baxter RC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1377-9. PubMed ID: 1720128
[TBL] [Abstract][Full Text] [Related]
7. Evidence that limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) occurs in the normal state outside of the bloodstream.
Lalou C; Binoux M
Regul Pept; 1993 Oct; 48(1-2):179-88. PubMed ID: 7505464
[TBL] [Abstract][Full Text] [Related]
8. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs.
Clemmons DR; Dehoff ML; Busby WH; Bayne ML; Cascieri MA
Endocrinology; 1992 Aug; 131(2):890-5. PubMed ID: 1379166
[TBL] [Abstract][Full Text] [Related]
9. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex.
Bang P; Brismar K; Rosenfeld RG
J Clin Endocrinol Metab; 1994 May; 78(5):1119-27. PubMed ID: 7513716
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma.
Lassarre C; Binoux M
Endocrinology; 1994 Mar; 134(3):1254-62. PubMed ID: 7509737
[TBL] [Abstract][Full Text] [Related]
11. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
[TBL] [Abstract][Full Text] [Related]
12. Proteolysis of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in 150-kilodalton IGFBP complexes by a cation-dependent protease activity in adult rat serum promotes the release of bound IGF-I.
Lee CY; Rechler MM
Endocrinology; 1996 May; 137(5):2051-8. PubMed ID: 8612547
[TBL] [Abstract][Full Text] [Related]
13. A major portion of the 150-kilodalton insulin-like growth factor-binding protein (IGFBP) complex in adult rat serum contains unoccupied, proteolytically nicked IGFBP-3 that binds IGF-II preferentially.
Lee CY; Rechler MM
Endocrinology; 1995 Feb; 136(2):668-78. PubMed ID: 7530649
[TBL] [Abstract][Full Text] [Related]
14. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells.
Blat C; Villaudy J; Binoux M
J Clin Invest; 1994 May; 93(5):2286-90. PubMed ID: 7514194
[TBL] [Abstract][Full Text] [Related]
15. Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat.
Unterman TG; Jentel JJ; Oehler DT; Lacson RG; Hofert JF
Endocrinology; 1993 Dec; 133(6):2531-9. PubMed ID: 7694841
[TBL] [Abstract][Full Text] [Related]
16. Structural determinants for binary and ternary complex formation between insulin-like growth factor-I (IGF-I) and IGF binding protein-3.
Baxter RC; Bayne ML; Cascieri MA
J Biol Chem; 1992 Jan; 267(1):60-5. PubMed ID: 1370451
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
[TBL] [Abstract][Full Text] [Related]
18. Characterization of insulin-like growth factor binding proteins (IGFBPs) during gestation in mice: effects of hypophysectomy and an IGFBP-specific serum protease activity.
Fielder PJ; Thordarson G; Talamantes F; Rosenfeld RG
Endocrinology; 1990 Nov; 127(5):2270-80. PubMed ID: 1699743
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of the acid-labile subunit of the growth-hormone-dependent insulin-like-growth-factor-binding protein complex by rat hepatocytes in culture.
Scott CD; Baxter RC
Biochem J; 1991 Apr; 275 ( Pt 2)(Pt 2):441-6. PubMed ID: 1709006
[TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy.
Langford KS; Nicolaides KH; Jones J; Abbas A; McGregor AM; Miell JP
J Clin Endocrinol Metab; 1995 Jan; 80(1):21-7. PubMed ID: 7530257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
